This company has been marked as potentially delisted and may not be actively trading. Cyclacel Pharmaceuticals (CYCCP) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsDividendFDA EventsHeadlinesShort InterestTrendsBuy This Stock CYCCP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business UpdateAugust 13, 2025 | globenewswire.comCYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIBAugust 4, 2025 | globenewswire.comWhy Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday?July 15, 2025 | benzinga.comCYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER - MorningstarJuly 8, 2025 | morningstar.comMCyclacel Pharmaceuticals Highlights Study on PLK1 Inhibitor Potential for Treating Fibrolamellar Hepatocellular CarcinomaJuly 7, 2025 | quiverquant.comQCYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENTJuly 7, 2025 | globenewswire.comCYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCERJuly 7, 2025 | globenewswire.comCyclacel Pharmaceuticals Announces Stock SplitJuly 2, 2025 | globenewswire.comCyclacel Pharmaceuticals, Inc. (CYCC) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comCyclacel Pharmaceuticals Secures $3 Million in Private Placement of Convertible Preferred StockJune 20, 2025 | quiverquant.comQCyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred StockJune 20, 2025 | globenewswire.comCyclacel Stock Tumbles Over 76% Since Regaining Nasdaq Compliance: What’s Ailing the Nanocap Biopharma Firm?June 20, 2025 | msn.comCYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTJune 3, 2025 | globenewswire.comCYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATEMay 14, 2025 | globenewswire.comCYCLACEL PHARMACEUTICALS ANNOUNCES STOCK SPLITMay 7, 2025 | globenewswire.comCYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN.May 6, 2025 | globenewswire.comCyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business UpdateApril 2, 2025 | globenewswire.comCyclacel Pharmaceuticals Delays 10-K FilingMarch 31, 2025 | tipranks.comCyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred StockMarch 24, 2025 | globenewswire.comCyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive LeadershipFebruary 27, 2025 | globenewswire.comCyclacel Pharmaceuticals streamlines operations, plans asset purchaseFebruary 6, 2025 | msn.comCyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David LazarJanuary 3, 2025 | globenewswire.comCyclacel Pharmaceuticals Exploring Alternatives, Cuts Costs to Preserve CashDecember 5, 2024 | marketwatch.comCyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating CostsDecember 5, 2024 | globenewswire.comCyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross ProceedsNovember 14, 2024 | globenewswire.comCyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross ProceedsNovember 13, 2024 | globenewswire.comCyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business UpdateNovember 12, 2024 | globenewswire.comCyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard RuleOctober 24, 2024 | globenewswire.comCyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR SymposiumOctober 23, 2024 | globenewswire.comCyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR SymposiumOctober 9, 2024 | globenewswire.comCyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 StudySeptember 25, 2024 | globenewswire.comCyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comCyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting LetterSeptember 3, 2024 | globenewswire.comCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comCYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024August 14, 2024 | markets.businessinsider.comCyclacel Pharmaceuticals, Inc. (CYCC) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comCyclacel Pharmaceuticals earnings: here's what Wall Street expectsAugust 13, 2024 | markets.businessinsider.comCyclacel Pharmaceuticals to Release Second Quarter 2024 Financial ResultsAugust 7, 2024 | globenewswire.comCyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical CompositionsJune 26, 2024 | globenewswire.comCyclacel's Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual MeetingJune 4, 2024 | globenewswire.comCyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...May 15, 2024 | finance.yahoo.comCyclacel Pharmaceuticals GAAP EPS of -$2.27 beats by $2.48May 14, 2024 | msn.comCyclacel Pharmaceuticals to Release First Quarter 2024 Financial ResultsMay 8, 2024 | globenewswire.comCyclacel Pharmaceuticals files to sell 15.2M shares for holdersMay 6, 2024 | msn.comCyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ RulesMay 2, 2024 | markets.businessinsider.comCyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ RulesMay 2, 2024 | globenewswire.com$8 Million Private Placement Announcement Sends Biotech FlyingApril 30, 2024 | msn.comWhy Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?April 30, 2024 | investorplace.comCyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesApril 30, 2024 | globenewswire.comCyclacel Pharmaceuticals Withdraws Securities Offering SEC FilingApril 30, 2024 | marketwatch.com Get Cyclacel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCCP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYCCP Media Mentions By Week CYCCP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYCCP News Sentiment▼0.000.78▲Average Medical News Sentiment CYCCP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYCCP Articles This Week▼00▲CYCCP Articles Average Week Get the Latest News and Ratings for CYCCP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Jasper Therapeutics News Today NewAmsterdam Pharma News Today Nutriband News Today Reviva Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYCCP) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCCP Stock Alerts